These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16928188)

  • 1. Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system.
    Soderberg-Naucler C
    Crit Rev Immunol; 2006; 26(3):231-64. PubMed ID: 16928188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?
    Söderberg-Nauclér C
    J Intern Med; 2006 Mar; 259(3):219-46. PubMed ID: 16476101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of host immune defenses by cytomegalovirus: advanced insights from evolutionary game theory].
    Zheng Q; Tao R; Shang SQ
    Bing Du Xue Bao; 2013 Jan; 29(1):85-91. PubMed ID: 23547385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomegalovirus (CMV)].
    Kosugi I
    Uirusu; 2010 Dec; 60(2):209-20. PubMed ID: 21488334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology.
    Loenen WA; Bruggeman CA; Wiertz EJ
    Semin Immunol; 2001 Feb; 13(1):41-9. PubMed ID: 11289798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCMV microinfections in inflammatory diseases and cancer.
    Söderberg-Nauclér C
    J Clin Virol; 2008 Mar; 41(3):218-23. PubMed ID: 18164235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.
    Loewendorf A; Benedict CA
    J Intern Med; 2010 May; 267(5):483-501. PubMed ID: 20433576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus persistence.
    Goodrum F; Caviness K; Zagallo P
    Cell Microbiol; 2012 May; 14(5):644-55. PubMed ID: 22329758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
    El Baba R; Herbein G
    Front Immunol; 2021; 12():730765. PubMed ID: 34566995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus and the aging population.
    Emery VC
    Drugs Aging; 2001; 18(12):927-33. PubMed ID: 11888347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
    Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
    Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
    Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interplay between Human Cytomegalovirus and Pathogen Recognition Receptor Signaling.
    Marques M; Ferreira AR; Ribeiro D
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30241345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
    Gredmark-Russ S; Söderberg-Nauclér C
    Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCMV infection: modulating the cell cycle and cell death.
    Castillo JP; Kowalik TF
    Int Rev Immunol; 2004; 23(1-2):113-39. PubMed ID: 14690857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
    Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of human cytomegalovirus pathogenesis.
    Nogalski MT; Collins-McMillen D; Yurochko AD
    Methods Mol Biol; 2014; 1119():15-28. PubMed ID: 24639215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus and Autoimmune Diseases: Where Are We?
    Gugliesi F; Pasquero S; Griffante G; Scutera S; Albano C; Pacheco SFC; Riva G; Dell'Oste V; Biolatti M
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33567734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.